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Introduction 
Aspetic meningitis secondary to drug 
adverse effects is a rare but serious disorder, 
most commonly reported with non-steroidal 
anti-inflammatory drugs and trimethoprim 
and sulfamethoxazole (TMP-SMX). Early 
diagnosis is important, since the cessation of 
the problem drug leads to rapid clinical 
improvement. We report a case of TMP-
SMX induced meningitis. 
 
Case Report 
A 24-year-old previously healthy man 
was admitted after a four-day history of 
severe headaches, neck stiffness, nausea, 
vomiting, and low grade fever and chills.  
He had been taking TMP-SMX for 18 days 
for a suspected community-acquired 
methicillin-resistant Staphylococcus aureus 
(MRSA) abscess of his right groin.  In 
addition, he noticed sudden onset of a 
diffuse maculo-papular rash on the day of 
presentation sparing only his face and 
palms.  
The patient denied any history of contact 
with infected individuals, cough, or sinus 
discharges.  His past medical history was 
negative.  He had never taken TMP-SMX. 
He smoked cigarettes, but did not report any 
alcohol or illicit drug use. He had no known 
medication allergy.  On presentation, he was 
awake and oriented. 
On physical examination, the patient 
showed a positive Brudzinski sign and the 
rash as described above, as well as a painful,  
 
 
2x2 cm, right groin abscess.  Vital signs 
were remarkable for a temperature of 103°F 
and a heart rate of 103 bpm.   
A Complete Blood Count (CBC), 
Comprehensive Metabolic Profile, 
urinalysis, chest xray, and a brain CT scan 
were normal.  Lumbar puncture was 
significant for 427 WBCs with 93% 
segmented neutrophils, protein of 51, 
normal glucose, and and no organism on 
gram stain. The following tests were 
negative:  Rickettsia rickettsi serology, 
human immunodeficiency virus (HIV) 
antibody, Erlichia chaffensis serology, 
Lyme disease serology, herpes simplex virus 
polymerase chain reaction (PCR) on 
cerebrospinal fluid (CSF), Enterovirus PCR 
on CSF, Tularemia serology, cryptococcal 
antigen, Bartonella serology, venereal 
disease research laboratory (VDRL) test.  
Bacterial, viral, acid fast, and fungal cultures 
and stains also were negative. TMP-SMX 
was stopped on admission and the patient 
recovered within three days.  
 
Discussion 
TMP-SMX induced meningitis has been 
well reported in literature.  The reaction is 
idiosyncratic.1 The described symptoms can 
occur in patients naïve to TMP-SMX as well 
as previous users. These symptoms can 
occur hours to weeks following admin-
istration of the drug.  Meng et al.2 reported 
recurrent aseptic meningitis following TMP-
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SMX use for urosepsis four times in the 
same patient.   
The pathogenetic mechanism of this 
disease is still uncertain. Possible 
mechanisms      include        hypersensitivity 
reaction, direct drug toxicity, and immune 
complex deposition. Antonen et al.3 
suggested IL6 as a possible mediator.  
Symptoms usually include mild 
headache, low grade fever, and neck 
stiffness, although hemodynamic 
compromise and respiratory failure requiring 
intubation and admission to the intensive 
care unit also have been reported.1  
Cerebrospinal fluid analysis suggestive of 
TMP-SMX induced meningitis includes a 
neutrophilic pleocytosis and mildly elevated 
protein along with normal glucose and 
negative gram stain.1   
Some reports suggested that CSF fluid 
findings alone cannot differentiate between 
TMP-SMX induced meningitis and partially 
treated bacterial or viral meningitis.4 Brain 
CT scan is normal in most case reports. 
Blumenfeld et al.5 described MRI findings 
consistent with diffuse bilateral T2 signal 
abnormalities of the white matter of the 
cerebral hemispheres.  
Recovery after discontinuation of the 
drug, and negative viral, bacterial, and 
fungal cultures are strongly suggestive of 
TMP-SMX induced meningitis. Fortunately, 
recovery is complete most of the time and 
uneventful within 3 to 11 days, even in the 
case of most severe symptoms. 
 
Conclusion 
The incidence of TMP-SMX induced 
meningitis is unknown.  It does not appear 
to be dose or time related.  Neutrophilic 
pleocytosis and negative cultures are 
essential for the diagnosis. Treatment is 
discontinuation of the drug.  Prognosis is 
usually excellent.  
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